...
首页> 外文期刊>World Journal of Gastroenterology >Effects of Zhaoyangwan on chronic hepatitis B and posthepatic cirrhosis
【24h】

Effects of Zhaoyangwan on chronic hepatitis B and posthepatic cirrhosis

机译:朝阳丸对慢性乙型肝炎和肝硬化后的影响

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To study the therapeutic effects of zhaoyangwan (ZYW) on chronic hepatitis B and hepatic cirrhosis and the anti-virus, anti-fibrosis and immunoregulatory mechanisms of ZYW. METHODS: Fifty cases of chronic hepatitis B and posthepatic cirrhosis with positive serum HBsAg, HBeAg, anti-Hbc and HBV-DNA were divided randomly and single-blindly into the treatment group (treated with ZYW) and the control group (treated with interferon). After 3 month treatment, the effects of the treatment group and the control group were evaluated. RESULTS: The serum ALT normalization was 83.3%(30/36) in the treatment group and 85.7%(12/14) in the control group, with no significant difference (χ~2=0.043, P>0.05). After the course, the negative expression rates of the serum HBV-DNA and HBeAg were 44.4%(16/36) and 50%(18/36) in the treatment group, and 50%(7/14) and 50%(7/14) in the control group, respectively, with no significant difference (χ~2=0.125, χ~2=0.00, both P>0.05). Negative HBsAg and positive HBsAb appeared in 4 cases of the treatment group and 1 case of the control group. Serum anti-HBc turned negative in 6 cases of the treatment group and 1 case of the control group, respectively. After the ZYW treatment, serum CD_3~+, CD_4~+ CD_8~+, CD_4~+/CD_8~+ and NK cell activation were significantly increased. Only serum CD_3~+ and NK cell activation were significantly increased in the control group with a significant difference between the two groups. The serum C_4, C_(1q), C_3, B and C_9 were significantly increased in the treatment group. In the control group only the serum C_4 was increased. The concentration of serum interferon had no change after treatment with ZYW, while it was significantly increased in the control group after treatment with interferon. The ultrastructure of the liver restored, which helped effectively to reduce the degeneration and necrosis of hepatic cells, infiltration of inflammatory cells and hepatic cirrhosis. CONCLUSION: ZYW is a pure Chinese herbal medicine. It can exert potent therapeutic effects on chronic hepatitis B and posthepatic cirrhosis. ZYW has similar therapeutic effects to those of interferon. It is cheap and easily administered with no obvious side-effects. It can be widely used in clinical practice.
机译:目的:研究招阳丸对慢性乙型肝炎和肝硬化的治疗作用,并探讨其抗病毒,抗纤维化及免疫调节机制。方法:将50例血清HBsAg,HBeAg,抗Hbc和HBV-DNA阳性的慢性乙型肝炎和肝硬化患者随机分为治疗组(ZYW治疗)和对照组(干扰素治疗)。 。治疗3个月后,评价治疗组和对照组的效果。结果:治疗组血清ALT正常化率为83.3%(30/36),对照组为85.7%(12/14),差异无统计学意义(χ〜2 = 0.043,P> 0.05)。疗程结束后,治疗组血清HBV-DNA和HBeAg的阴性表达率分别为44.4%(16/36)和50%(18/36),分别为50%(7/14)和50%(7)。 / 14)分别与对照组无显着性差异(χ〜2 = 0.125,χ〜2 = 0.00,均P> 0.05)。治疗组4例和对照组1例出现阴性HBsAg和阳性HBsAb。治疗组6例和对照组1例血清抗HBc转阴。 ZYW治疗后,血清CD_3〜+,CD_4〜+ CD_8〜+,CD_4〜+ / CD_8〜+和NK细胞活化显着增加。对照组中仅血清CD_3〜+和NK细胞活化显着增加,两组之间有显着差异。治疗组血清C_4,C_(1q),C_3,B和C_9明显升高。在对照组中,仅血清C_4增加。 ZYW治疗后血清干扰素浓度无变化,而对照组则明显升高。肝脏的超微结构得以恢复,从而有效地减少了肝细胞的变性和坏死,炎性细胞浸润和肝硬化。结论:ZYW是一种纯中草药。它可以对慢性乙型肝炎和肝硬化后产生有效的治疗作用。 ZYW具有与干扰素相似的治疗作用。它便宜且易于管理,没有明显的副作用。可在临床实践中广泛使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号